中国医学前沿杂志（电子版）
中國醫學前沿雜誌（電子版）
중국의학전연잡지（전자판）
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2014年
9期
42-44
,共3页
鼻咽癌%放疗%复发%再程放疗%疗效分析
鼻嚥癌%放療%複髮%再程放療%療效分析
비인암%방료%복발%재정방료%료효분석
Nasopharyngeal carcinoma%Radiation therapy%Relapse%Re-irradiation radiotherapy%Efifcacy analysis
目的：分析比较鼻咽癌放疗后复发行再程放疗的疗效。方法选取本院经放疗后复发行再程放疗的鼻咽癌患者80例为研究对象，回顾性分析其复发后行再程放疗的效果、并发症、3年生存率及5年生存率。结果患者接受再程调强放疗后总有效率为72.5%；所有患者癌细胞均得到控制，未发生严重并发症，对症治疗后症状缓解；持续5年随访，3年生存率为71.25%，5年生存率为21.25%，死亡率为41.25%。结论①放疗后复发的鼻咽癌患者行再程放疗后，临床疗效显著，并发症少，提高患者的生存率；②患者复发时间越早，再程放疗疗效越显著，鼻咽癌肿瘤靶区的划分和化疗是预后的关键因素。
目的：分析比較鼻嚥癌放療後複髮行再程放療的療效。方法選取本院經放療後複髮行再程放療的鼻嚥癌患者80例為研究對象，迴顧性分析其複髮後行再程放療的效果、併髮癥、3年生存率及5年生存率。結果患者接受再程調彊放療後總有效率為72.5%；所有患者癌細胞均得到控製，未髮生嚴重併髮癥，對癥治療後癥狀緩解；持續5年隨訪，3年生存率為71.25%，5年生存率為21.25%，死亡率為41.25%。結論①放療後複髮的鼻嚥癌患者行再程放療後，臨床療效顯著，併髮癥少，提高患者的生存率；②患者複髮時間越早，再程放療療效越顯著，鼻嚥癌腫瘤靶區的劃分和化療是預後的關鍵因素。
목적：분석비교비인암방료후복발행재정방료적료효。방법선취본원경방료후복발행재정방료적비인암환자80례위연구대상，회고성분석기복발후행재정방료적효과、병발증、3년생존솔급5년생존솔。결과환자접수재정조강방료후총유효솔위72.5%；소유환자암세포균득도공제，미발생엄중병발증，대증치료후증상완해；지속5년수방，3년생존솔위71.25%，5년생존솔위21.25%，사망솔위41.25%。결론①방료후복발적비인암환자행재정방료후，림상료효현저，병발증소，제고환자적생존솔；②환자복발시간월조，재정방료료효월현저，비인암종류파구적화분화화료시예후적관건인소。
Objective To study the efficacy of reirradiation therapy after relapse of patients subject to nasopharyngeal carcinoma radiotherapy, and to conduct analysis and comparison. Method Eighty patients subject to re-irradiation radiotherapy therapy after relapse of nasopharyngeal carcinoma radiotherapy in the inpatient department of this hospital, and the efficacy, complications, 3-year survival rate and the 5-year survival rate of re-irradiation radiotherapy therapy were retrospectively analyzed. Result The total effective rate of patients subject to re-irradiation radiotherapy therapy was 72.5%, cancer cells of all patients were controlled, no serious complications occurred, and symptoms were relieved upon symptomatic treatment. The 3-year survival rate of patients was 71.25%after continual follow-ups of 5 years, and the 3-year survival rate of patients was 21.25%. The 5-year mortality was 41.25%after follow-ups. Conclusion ①Clinical efifcacy of re-irradiation radiotherapy therapy on patients subject to nasopharyngeal carcinoma is signiifcant, a few complications are found, and the survival rate of patients can be improved.②The therapy efifcacy of reirra-diation therapy on patients was more signiifcant than the earlier relapse time of patients, and the division and chemotherapy for nasopharyngeal tumor target are key factors of prognosis factor.
